News

World Cancer Day, February 4, is an opportunity to remember that 50% of people with cancer are afraid to talk to their employer about it. To break down prejudice and stop the stigmatization of the disease in the workplace, the Publicis Foundation is launching a global campaign entitled "Working with cancer". Gustave Roussy and the Cancer At Work...

Gustave Roussy comes in 3rd place in the ranking of specialized hospitals published by the American magazine Newsweek.

Laurence Zitvogel, french oncologist at Gustave Roussy is receiving this year’s Bob Pinedo Cancer Care Award for her pioneering research and passionate commitment to improving the quality of treatment and care for cancer patients.

The annual congress of the European Society of Medical Oncology (ESMO) will be held in Paris from September 9 to 13, 2022. This major cancer research event will present the main advances in clinical research. Gustave Roussy is one of the major players in this event and will, at this occasion, announce the launch of its Alumni network.

Save the date : Friday the 13th of May 2:30 pm (CEST) for the first online conference dedicated to immuno-oncology set up between the Dana Farber Cancer Institute and Gustave Roussy/Paris-Saclay University.

Delivering radiotherapy in 5 days instead of 3 to 5 weeks - this is the new challenge taken up by Gustave Roussy. The Institute now offers women over 60, with localised breast cancer, fewer but equally effective radiotherapy sessions after surgery. 

The Highly Cited Researchers 2021 list, published by Clarivate, identifies the most influential researchers as determined by their peers all around the world.

By an order, the Minister of Health and Solidarity, Mr. Olivier Véran, appointed Professor Fabrice Barlesi as General Director of Gustave Roussy for a term of five years from 1 August 2021. He succeeds Professor Jean-Charles Soria who will leave his position for family reasons. Professor Barlesi’s appointment ensures that Gustave Roussy will...

Sanofi, Gustave Roussy, Inserm, Institut Polytechnique de Paris and the University of Paris-Saclay are committed to developing personalized medicine in France through a patient-centered oncology cluster - the Paris Saclay Cancer Cluster.

Gustave Roussy is part of the best represented institutions at ASCO annual meeting.